Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Colorado Health Reporter.
Press releases published on August 13, 2025
Hermann Digital Media Presents David Hermann at Colorado Startup Week 2025: Optimizing the Entrepreneur’s Journey
EIN Presswire
·
August 13, 2025
Unlock practical strategies to build a thriving, sellable business and break free from founder burnout at Colorado Startup Week 2025. GREENWOOD VILLAGE, CO, UNITED STATES, August 13, 2025 /EINPresswire.com/ -- Hermann Digital Media and Sunbelt Business …
Banyan Castle Rock Celebrates One Year of Providing Life-Changing Addiction and Mental Health Treatment in Colorado
EIN Presswire
·
August 13, 2025
Banyan Castle Rock marks 1 year of providing medical detox, substance use residential care, and mental health treatment in Colorado. CASTLE ROCK, CO, UNITED STATES, August 13, 2025 /EINPresswire.com/ -- Banyan Treatment Centers is proud to announce the …
Pitcher Recognized in Five Gartner® Hype Cycle Reports ™ for Summer 2025
EIN Presswire
·
August 13, 2025
DENVER, CO, UNITED STATES, August 13, 2025 /EINPresswire.com/ -- Gartner has recognized Pitcher’s Sales Enablement 2.0 platform in five Gartner Hype Cycles published in July 2025. “Gartner Hype Cycles provide a graphic representation of the maturity …
Loveland Medical Assistant School Opens Doors to New Careers in Healthcare
EIN Presswire
·
August 13, 2025
18-week program blends classroom learning and hands-on training to prepare Loveland students for in-demand careers as certified medical assistants. LOVELAND, CO, UNITED STATES, August 13, 2025 /EINPresswire.com/ -- Loveland Medical Assistant School …
Biofrontera Inc. Reports Second Quarter 2025 Financial Results and Provides a Business Update
GlobeNewswire
·
August 13, 2025
Woburn, MA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy in dermatology, today reported financial results for the …
BioSig Technologies Inc. Announces Proposed Public Offering
GlobeNewswire
·
August 13, 2025
Los Angeles, CA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (“BioSig” or the “Company”) which recently merged with Streamex Exchange Corporation (“Streamex”) (NASDAQ: BSGM) today announced its intention to offer shares of common stock (or …
Applied Therapeutics Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 13, 2025
- CMT-SORD program advances; meeting scheduled with the FDA in Q3 2025 to discuss govorestat for the treatment of CMT-SORD - Presented full 12-month clinical results and new topline data from INSPIRE Phase 2/3 trial of govorestat for the treatment of CMT- …
Precipio Announces its Q2-2025 Financial Results
GlobeNewswire
·
August 13, 2025
NEW HAVEN, Conn., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), filed its 10-Q report today. The following are the highlights of the Company’s financial performance and outlook for 2025. “Yet another …
PharmaCorp Rx Inc. Announces New Credit Facilities With CIBC and Unveils Pharmacist Co-Ownership Financing Initiative
GlobeNewswire
·
August 13, 2025
SASKATOON, Saskatchewan, Aug. 13, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce that it has entered into a credit agreement with Canadian Imperial Bank of Commerce (“CIBC”) providing the …
LAVA Reports Second Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
August 13, 2025
Announced entry into an agreement to be acquired by XOMA Royalty Corporation for between $1.16 and $1.24 per share in cash, plus a contingent value right related to LAVA’s two partnered assets and unpartnered programs Consummation of acquisition expected …
Corza Medical ouvre un laboratoire d’innovation pour les textiles biomédicaux afin d’accélérer le développement de produits FEO
GlobeNewswire
·
August 13, 2025
TAUNTON, Royaume-Uni, 13 août 2025 (GLOBE NEWSWIRE) -- Corza Medical, l’un des principaux fabricants mondiaux de technologies chirurgicales et de composants de dispositifs médicaux, a annoncé aujourd’hui l’ouverture de son laboratoire d’innovation pour les …
Corza Medical eröffnet Innovationslabor für biomedizinische Textilien zur Beschleunigung der OEM-Produktentwicklung
GlobeNewswire
·
August 13, 2025
TAUNTON, Großbritannien, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Corza Medical, ein weltweit führender Hersteller chirurgischer Technologien und Komponenten für medizinische Geräte, hat heute die Eröffnung seines Innovationslabors für biomedizinische Textilien …
rYojbaba Co., Ltd. Announces Pricing of $5 Million Initial Public Offering of Japanese Common Shares and Listing on Nasdaq
GlobeNewswire
·
August 13, 2025
FUKUOKA, Japan, Aug. 13, 2025 (GLOBE NEWSWIRE) -- rYojbaba Co., Ltd. (“rYojbaba” or the “Company”), a Japanese labor consulting and health services company, today announced the pricing of its initial public offering of 1,250,000 Japanese common shares at …
2025 Winners of the 31st-Annual Eric Dostie Memorial College Scholarship Announced
GlobeNewswire
·
August 13, 2025
TEMECULA, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Nufactor®, a specialty infusion company and subsidiary of FFF Enterprises, Inc., is pleased to announce the names of its 2025 Eric Dostie Memorial College Scholarship recipients. The annual scholarship …
SCYNEXIS Reports Second Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
August 13, 2025
First new patient dosed in Phase 3 MARIO study following the lifting of the FDA clinical hold, triggering a $10M milestone payment from GSK. An additional $20M milestone will be triggered upon the six month anniversary of the new patient dosing; as …
Onco360 adds Modeyso™ (dordaviprone) to portfolio of Oncology and Rare Cancer therapies as a National Specialty Pharmacy Provider
GlobeNewswire
·
August 13, 2025
LOUISVILLE, Ky., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a pharmacy partner by Jazz Pharmaceuticals for Modeyso™ (dordaviprone). It is indicated for the treatment of adult and …
Aptose Reports Second Quarter 2025 Results
GlobeNewswire
·
August 13, 2025
Tuspetinib Continues to Demonstrate Excellent Safety and Complete Responses in the TUSCANY Clinical Trial of Tuspetinib in AML Triple Drug Frontline Therapy at 120 mg Dose Cohort Safety Review Committee (CSRC) Recommends Tuspetinib Dose Escalation to 160 …
Opus Genetics Announces Financial Results for Second Quarter 2025 and Provides Corporate Update
GlobeNewswire
·
August 13, 2025
- Positive 12-month Phase 1/2 clinical data in adult cohort and early pediatric clinical data support potential for meaningful vision restoration with OPGx-LCA5 - - FDA grants Regenerative Medicine Advanced Therapy (RMAT) designation for OPGx-LCA5 - - …
Vivani Medical Provides Business Update Including $10M Equity Financing and Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 13, 2025
Company plans rapid advancement of semaglutide implant NPM-139, following positive weight loss data from an ongoing preclinical study of NPM-139 and promising results from the LIBERATE-1 Phase 1 clinical study of NPM-115 New $10M equity financing to enable …
Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update
GlobeNewswire
·
August 13, 2025
Strong performance driven by over 200% growth in product revenues year-on-year Best quarter in Alvotech’s history in terms of operating cash flows Continued expansion of commercial partnerships for pipeline assets Alvotech listed on Nasdaq Stockholm Market …